Abstract
The stringent process of prior authorization (PA) has negative impacts on timeliness of treatments acting as an administrative burden for the payers, providers, and care delays for patients. This study focuses on deployment of PA analytics for a specialty product using advanced clinical, predictive, and prescriptive analytics and generating payer/provider insights for solving the challenge of drug abandonment and driving outcomes for patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
